Evidio Domingo-Musibay

Assistant Professor, Medicine - Hematology, Oncology, Transplant

Emailmusib024@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

8 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

4 Finished
8 Active

MT2020-36: A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of AutologousTumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma
Domingo-Musibay, E.
INSTIL BIO, INC
10/28/20 → 10/31/25
Project: Research project
Immunomodulatory affects of radioembolization: a prospective study of peripheral monocyte modulation, immune cell infiltration, and cytokine variation.
Young, S. J., Domingo-Musibay, E., Golzarian, J. & Lou, E.
RADIOLOGICAL SOC OF NORTH AMERICA
7/1/20 → 6/30/21
Project: Research project
Neoadjuvant therapy for patients with high risk stage III melanoma
Domingo-Musibay, E. & Holtan, S. G.
Mayo Clinic
6/1/18 → 5/31/21
Project: Research project
A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OFNKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMABIN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES
Domingo-Musibay, E.
NEKTAR THERAPEUTICS
5/1/18 → 5/31/22
Project: Research project
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM
12/1/17 → 1/31/22
Project: Research project

10 Article
3 Review article

Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients
Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E. & Steinberger, D., Feb 24 2021, In: Radiology.
Research output: Contribution to journal › Article › peer-review
Propranolol: What is BLOCKing its clinical investigation in breast cancer?
Blaes, A. H., Domingo-Musibay, E. & Kalinsky, K., Apr 15 2020, In: Clinical Cancer Research. 26, 8, p. 1781-1783 3 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Myoepithelioma of Soft Tissues A Single Institution Retrospective Case Series
Domingo-Musibay, E., Oliveira, A. M., Okuno, S. H., Petersen, I. A., Rose, P. S. & Robinson, S. I., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 4, p. 357-361 5 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Domingo-Musibay, E., Murugan, P., Giubellino, A., Sharma, S., Steinberger, D., Yuan, J., Hunt, M. A., Lou, E. & Miller, J. S., 2018, In: Journal for ImmunoTherapy of Cancer. 6, 1, 58.
Research output: Contribution to journal › Article › peer-review

Open Access
17 Scopus citations
Endogenous heat-shock protein induction with or without radiofrequency ablation or cryoablation in patients with stage IV melanoma
Domingo-Musibay, E., Heun, J. M., Nevala, W. K., Callstrom, M., Atwell, T., Galanis, E., Erickson, L. A. & Markovic, S. N., Sep 2017, In: Oncologist. 22, 9, p. 1026-e93
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations